Enveric Biosciences, Inc. Profile Avatar - Palmy Investing

Enveric Biosciences, Inc.

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related di…

Biotechnology
US, Naples [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Enveric Biosciences, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Enveric Biosciences, Inc. can't present revenue by segment

End of ENVB's Analysis
CIK: 890821 CUSIP: 29405E208 ISIN: US29405E2081 LEI: - UEI: -
Secondary Listings
ENVB has no secondary listings inside our databases.